← FDA Drug Approvals (Drugs@FDA)

SERPASIL-ESIDRIX #2

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 1959-05-05

Drug application

FDA Application #

NDA011878

Application type

New Drug Application

Brand name

SERPASIL-ESIDRIX #2

Generic name

Hydrochlorothiazide

Active ingredients

HYDROCHLOROTHIAZIDE; RESERPINE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

NOVARTIS

First approval

1959-05-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown